Latest News
Latest News
The better mammogram: Experts explore sensitivity of new modalities
PHILADELPHIA – Newer technologies such as tomosynthesis and molecular breast imaging could be especially helpful in screening women with dense...
Conference Coverage
Targeting PCSK9 inhibitors to reap most benefit
ANAHEIM, CALIF. – New FOURIER analyses show where evolocumab packs greatest payoff.
Conference Coverage
Direct oral anticoagulants okay during AF device placement
ANAHEIM, CALIF. – The clinical scenario, not hematoma or stroke risk, can guide the decision to continue DOACs during antiarrhythmic device...
Conference Coverage
CheckMate 214: Updated results for RCC focus on PD-L1 expression, QOL
NATIONAL HARBOR, MD. – Benefit from combination immune checkpoint inhibitor treatment for renal cell carcinoma patients was greatest with PD-L1–...
From the Journals
In children with ALL, physical and emotional effects persist
Evaluations of quality of life and family functioning as early as 2 months after diagnosis identified those at highest risk of continued...
Conference Coverage
DAPT produces better CABG outcomes than aspirin alone
ANAHEIM, CALIF. – Saphenous vein grafts had improved patency with ticagrelor plus aspirin, compared with aspirin alone.
Feature
Former pharma exec nominated for top HHS post
Alex Azar also served at HHS in the George W. Bush administration
From the Journals
Frailty, not age, predicted complications after ambulatory surgery
Frailty was associated with a significant increase in 30-day complications after ambulatory hernia repair.
News
MACRA Monday: Documenting current medications
Staying on top of a patient’s medication list could help you avoid a 4% MIPS penalty.
Conference Coverage
VIDEO: Evidence mounts for pulmonary embolism benefit from catheter thrombolysis
TORONTO – The treatment may be best suited to intermediate-risk PE patients.
News
FDA approves Cinvanti for chemo-induced nausea and vomiting
Patients on aprepitant injectable emulsion reported fewer adverse events, including substantially fewer infusion site reactions.